| T216 |
0-503 |
Sentence |
denotes |
6 28-02-2020; 01-03-2020 to 17-02-2021 0Not recruiting ChiCTR2000030088;http://www.chictr.org.cn/showproj.aspx?proj=49779 Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19) CIK and NK cells 90 Experimental groups:CIK group: UCB CIK cells (1.6×108 cells·kg−1) injected twice every other dayNK group: UCB NK cells (1.6×108 cells·kg−1) injected twice every other dayControl group: conventional therapy |
